More reads
- States, eager to lower drug prices, regroup after courts strike down Maryland ‘price-gouging’ law. (STAT)
- Big pharma is embracing open-access publishing like never before. (Nature)
- Mirati bulls will need patience. (EP Vantage)
- FDA sounds an alarm on using robotic devices in cancer surgeries, citing concerns about safety and results. (STAT)
.png)
No hay comentarios:
Publicar un comentario